Suvorexant | Insomnia | Depression

suvorexant | maher law firm | frank eidson

Merck & Co.’s drug, Suvorexant, has some troubling side effects Suvorexant is the first insomnia treatment of its kind to be submitted to the FDA (Food and Drug Administration) for approval.  The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee is discussing Merck & Co.’s new drug application for insomnia. Suvorexant side effects include, [...]